Condensed Consolidated Balance Sheets (Unaudited) - USD ($)	Jun. 30, 2021	Dec. 31, 2020
Current assets
Cash and cash equivalents	$ 10,840	$ 1,908
Prepaid expenses and other assets	27,104	0
Loan receivable from Emergence Global Enterprises Inc. - related party	0	17,901
Total current assets	37,944	19,809
Other assets
Other receivable	24,629	113,999
Note receivable - CEN Biotech Ukraine LLC - related party	44,859	44,859
Advances to CEN Biotech Ukraine LLC - related party	1,299,328	1,179,328
Intangible assets, net	4,743,741	4,956,147
Total assets	6,150,501	6,314,142
Current liabilities
Accounts payable	262,529	190,716
Accounts payable – related parties	8,347	8,347
Loans payable	785,618	527,379
Loans payable – related parties	1,314,395	1,363,354
Convertible notes payable	2,115,390	6,652,448
Convertible notes payable- related parties	2,419,983	2,558,681
Accrued interest	1,295,080	1,125,034
Accrued interest – related parties	1,720,575	1,615,880
Lease liabilities	36,670	22,895
Accrued expenses	705,633	641,023
Total current liabilities	10,664,220	14,705,757
Operating lease liabilities, less current portion	139,076	142,102
Patent acquisition liability	302,000	1,380,000
Convertible notes, less current portion	24,000	78,000
Total liabilities	11,129,296	16,305,859
Shareholders’ deficit
Common stock; unlimited authorized shares; 43,142,060 and 27,557,363 issued and outstanding as of June 30, 2021 and December 31, 2020, respectively. No par value.	0	0
Additional paid-in capital	38,197,932	17,068,810
Accumulated deficit	(43,176,727)	(27,060,527)
Total shareholders’ deficit	(4,978,795)	(9,991,717)
Total liabilities and shareholders’ deficit	$ 6,150,501	$ 6,314,142